Back to Journals » Journal of Hepatocellular Carcinoma » Volume 10

Boron Neutron Capture Therapy Eliminates Radioresistant Liver Cancer Cells by Targeting DNA Damage and Repair Responses [Corrigendum]

Authors Huang CY, Lai ZY , Hsu TJ , Chou FI, Liu HM, Chuang YJ 

Received 13 July 2023

Accepted for publication 13 July 2023

Published 26 July 2023 Volume 2023:10 Pages 1207—1208

DOI https://doi.org/10.2147/JHC.S430407



Huang CY, Lai ZY, Hsu TJ, Chou FI, Liu HM, Chuang YJ. J Hepatocell Carcinoma. 2022;9:1385–1401.

The authors have advised due to an error at the time of figure assembly, Figure 7A on page 1395 is incorrect. The western blots for the 10-hour timepoint in Figure 7A was duplicated from the western blots of the 24-hour timepoint in Figure 7B. The correct Figure 7 is shown below.

Figure 7 Boron neutron capture therapy increased G2/M arrest by altering CHK2 and CDK1 (CDC2) checkpoint signaling. Western blot assay for the G2/M checkpoint regulation-related proteins pCHK2, CHK2, pCDK1 (CDC2) (Y15), pCDK1 (pCDC2) (T161), and CDK1 (CDC2) at 10 hours (A) and 24 hours (B) post-irradiation. *p<0.05, **p<0.01, ***p<0.001.

The authors apologize for this error and advise it does not affect the results of the paper.


Read the original article


Creative Commons License © 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.